CORC

浏览/检索结果: 共18条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial 期刊论文
ONCOLOGIST, 2019, 卷号: 24, 期号: 8, 页码: E702-E708
作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Yan;  Luo, Hong;  Ren, Xiu-Bao
收藏  |  浏览/下载:27/0  |  提交时间:2019/12/11
A Phase III randomized controlled trial of oral dydrogesterone versus intravaginal progesterone gel for luteal phase support in in vitro fertilization (Lotus II): results from the Chinese mainland subpopulation 期刊论文
Gynecological Endocrinology, 2019
作者:  Yang D.-Z.;  Griesinger G.;  Wang W.;  Gong F.;  Liang X.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/11
A Randomized Phase III Study of Cisplatin-Polymeric Micelle Paclitaxel vs Cisplatin-Solvent-Based Paclitaxel in 1st Line Advanced NSCLC 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 10, 页码: S304-S304
作者:  Wu, Y.;  Han, B.;  Shi, M.;  Tu, H.;  Gu, A.
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/11
BIOSIMILAR BAT1406 VERSUS ADALIMUMAB THERAPY ON ACTIVE ANKYLOSING SPONDYLITIS: A RANDOMIZED, DOUBLE-BLINDED, MULTICENTER, CONTROLLED PHASE 3 TRIAL 会议论文
Annual European Congress of Rheumatology (EULAR), JUN 12-15, 2019
作者:  Tu, Liudan;  Wei, Qiujing;  Xie, Ya;  Shi, Guixiu;  Liu, Huaxiang
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/31
Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial 期刊论文
ONCOLOGY LETTERS, 2018, 卷号: 15, 期号: 3, 页码: 3646-3652
作者:  Li, Li;  Zhuang, Qingqing;  Cao, Zeyi;  Yin, Rutie;  Zhu, Yaping
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/11
Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer 期刊论文
LUNG CANCER, 2018, 卷号: 122, 页码: 32-37
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/11
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial 期刊论文
JAMA ONCOLOGY, 2018, 卷号: 4, 期号: 11, 页码: 1569-1575
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/11
Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial 期刊论文
HUMAN REPRODUCTION, 2018, 卷号: 33, 期号: 12, 页码: 2212-2221
作者:  Griesinger, Georg;  Blockeel, Christophe;  Sukhikh, Gennady T.;  Patki, Ameet;  Dhorepatil, Bharati
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/11
The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2018, 卷号: 13, 期号: 10, 页码: S505-S505
作者:  Si, X.;  Zhang, L.;  Wang, H.;  Zhang, X.;  Wang, M.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/11
Postoperative chemotherapy with S-1 plus oxaliplatin versus S-1 alone in locally advanced gastric cancer (RESCUE-GC study): a protocol for a phase III randomized controlled trial 期刊论文
中国癌症研究(英文版), 2017, 卷号: 29, 期号: 2, 页码: 144-148
作者:  Hu, Xiang;  Chen, Lin;  Du, Yian;  Fan, Biao;  Bu, Zhaode
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/11


©版权所有 ©2017 CSpace - Powered by CSpace